Akari Therapeutics (AKTX) Shares Issued (2012 - 2025)

Akari Therapeutics has disclosed Shares Issued across 9 years of filings, most recently posting $1.0 million for Q4 2025.

• Shares Issued for Q4 2025 came in at $1.0 million, up 3803.7% year-over-year; the trailing twelve-month figure through Dec 2025 was $6.9 million (up 343850.0% YoY), and the FY2025 annual result was $10.7 million, up 536150.0% from the prior year.
• Shares Issued came in at $1.0 million for Q4 2025 at Akari Therapeutics, down from $4.8 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $5.4 million in Q4 2021 to a low of -$1.7 million in Q2 2024.
• The 4-year median for Shares Issued is $1.7 million (2023), against an average of $1.8 million.
• Across the five-year window, Shares Issued slumped 101.5% in 2024 and jumped 3803.7% in 2025, its largest moves.
• Akari Therapeutics' Shares Issued stood at $5.4 million in 2021, then slumped by 66.67% to $1.8 million in 2023, then tumbled by 101.5% to -$27000.0 in 2024, then surged by 3803.7% to $1.0 million in 2025.
• The last three Shares Issued figures came in at $1.0 million (Q4 2025), $4.8 million (Q2 2025), and $1.1 million (Q1 2025), per Business Quant data.